35General restrictions

35 General restrictions

A price information list must not: (a) present or describe a medicine in a way that directs consumers to a particular medicine over and above any other medicine, whether or not that particular medicine is mentioned in the price information list; or (b) be accompanied by any promotional statement, pictorial representation or design; or (c) include: (i) an adjective or phrase that qualifies the name, formulation or pack size of the medicine; or (ii) a term indicating the predicted or recommended length of supply; or (iii) any embellishment; or (d) promote the purchase of quantities or multiple pack sizes that are not accepted in relation to the inclusion of the goods in the Register, except as provided under section 34; or (e) use a comparative adjective or term to qualify the purchase price of the medicine; or (f) give any prominence to the text of the name, description or purchase price of a particular medicine compared to any other medicine in the price information list; or (g) offer rewards or bonus points, or be associated with any other advertising that promotes rewards or bonus points; or (h) limit or qualify the availability of the price, other than by including a statement of validity or expiration of the purchase price; or (i) be accompanied by, or located in proximity to, information (including implications or references to other sources of information) regarding indications, diseases, conditions, ailments or defects, so that a reasonable person might infer that the medicine would cure or alleviate those diseases, conditions, ailments or defects.